MRNA · News · 20260731N
Guidance / Outlook
Moderna, Inc. · 2026-07-31 · Importance 85 · Surprise 76 · No source text
Moderna reiterated its 2026 target of up to 10% revenue growth. The company reduced its 2026 GAAP operating-expense outlook by approximately $200 million from its previous estimate. It also raised expected year-end 2026 cash and investments to approximately $4.7 billion to $5.2 billion, reflecting planned cost reductions and liquidity preservation.
Key facts
- Moderna reiterated a plan to deliver up to 10% revenue growth in 2026. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| revenue | positive | probable | +2.5% | Moderna reiterated a plan to deliver up to 10% revenue growth in 2026. |